Please use this identifier to cite or link to this item:
Title: Hepatitis B and A vaccination in HIV-infected adults: A review
Author: Mena, Guillermo
García-Basteiro, Alberto L.
Bayas Rodríguez, José María
Keywords: Hepatitis A
Hepatitis B
Malalts de sida
Hepatitis A
Hepatitis B
AIDS patients
Issue Date: 24-Jul-2015
Publisher: Taylor & Francis Group
Abstract: Hepatitis B and A account for considerable morbidity and mortality worldwide. Immunization is the most effective means of preventing hepatitis B and A. However, the immune response to both hepatitis vaccines seems to be reduced in HIV-infected subjects. The aim of this review was to analyze the immunogenicity, safety, long-term protection and current recommendations of hepatitis B and A vaccination among HIV-infected adults. The factors most frequently associated with a deficient level of anti-HBs or IgG anti-HAV after vaccination are those related to immunosuppression (CD4 level and HIV RNA viral load) and to the frequency of administration and/or the amount of antigenic load per dose. The duration of the response to both HBV and HAV vaccines is associated with suppression of the viral load at vaccination and, in the case of HBV vaccination, with a higher level of antibodies after vaccination. In terms of safety, there is no evidence of more, or different, adverse effects compared with HIV-free individuals. Despite literature-based advice on the administration of alternative schedules, revaccination after the failure of primary vaccination, and the need for periodic re-evaluation of antibody levels, few firm recommendations are found in the leading guidelines.
Note: Reproducció del document publicat a:
It is part of: Human Vaccines & Immunotherapeutics, 2015, vol. 11, num. 11, p. 2582-2598
Related resource:
ISSN: 2164-5515
Appears in Collections:Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
mena2015_2021.pdf682.54 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons